Results 121 to 130 of about 185,337,068 (295)

Characteristics of patients with diagnosis of maturity-onset diabetes of the young, according to the Russian diabetes registry

open access: yesСахарный диабет
BACKGROUND: Molecular genetic testing (MGT) is increasingly accessible, improving diagnosis of monogenic diabetes (DM), particularly maturity-onset diabetes of the young (MODY).
N. V. Rusyaeva   +5 more
doaj   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Maturity-onset diabetes of the young with necrobiosis lipoidica and granuloma annulare

open access: yes, 2006
We describe a 12-year-old white girl with granuloma annulare localized to both ankles since she was five, necrobiosis lipoidica in the left pretibial region since she was ten, and a recent history of weakness, migraine, and weight loss.
VENTURA, ALESSANDRO   +16 more
core   +1 more source

Outcomes of patients with post‐stroke epilepsy: A scoping review on quality of life, readmissions, costs, seizure recurrence, and medication adherence

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Post‐stroke epilepsy (PSE) affects ≈10% of patients with stroke and is associated with adverse health and economic outcomes. We aimed to review published literature on health and economic outcomes for patients with PSE, with a specific focus on quality of life, hospital readmissions, healthcare costs, seizure recurrence, and ...
Nega Dagnew Baye   +5 more
wiley   +1 more source

Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.

open access: yes, 2007
An important question in human genetics is the extent to which genes causing monogenic forms of disease harbor common variants that may contribute to the more typical form of that disease.
Walker, Mark   +21 more
core   +1 more source

Examining the clinical and genetic spectrum of maturity-onset diabetes of the young (MODY) in Iran

open access: yesScientific Reports
Maturity-onset diabetes of the young (MODY) is an uncommon monogenic type of diabetes mellitus. Detecting genetic variants for MODY is a necessity for precise diagnosis and treatment.
Sara Asgarian   +17 more
doaj   +1 more source

Health Services Utilization by Individuals With Eating Disorders in Norway: A Nationwide Register‐Linkage Study

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Objective This study investigated healthcare utilization by individuals with an eating disorder (ED) stratified by age and ED diagnosis. Method Data were retrieved from the Norwegian Patient Registry (NPR) and the Control and Payment of Health Reimbursements (KUHR).
Anne Martina Kraus   +4 more
wiley   +1 more source

Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion

open access: yesExploration, EarlyView.
Over the past decades, chimeric antigen receptor (CAR)‐T cell therapy has evolved from a linear engineering concept into a powerful yet constrained immunotherapy, limited by tumour microenvironment barriers, immune evasion, and manufacturing complexity.
Yuesong Bai   +5 more
wiley   +1 more source

Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2019
Tatsuhiko UrakamiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, JapanAbstract: Maturity-onset diabetes of the young (MODY) is characterized by autosomal dominant inheritance, onset before 25 years of age, absence of β-cell ...
Urakami T
doaj  

Case Report: long-term misdiagnosis and follow-up of a patient with HNF4A-MODY carrying a new de novo mutation

open access: yesFrontiers in Endocrinology
BackgroundHNF4A-MODY constitutes 5%–10% of MODY cases; however, treatment options remain unclearly recommended, and long-term follow-up of patients with HNF4A-MODY is lacking due to limited research.
Jing Luo   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy